HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) - ANVISA Registration 80537410148

Access comprehensive regulatory information for HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80537410148 and manufactured by GUANGZHOU WONDFO BIOTECH CO. LTD. The registration is held by CELER BIOTECNOLOGIA S/A with validity until Sep 08, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS INC., ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.